Top Stories
CT-155 improved motivation and pleasure-related negative symptoms when used alongside antipsychotic medication, with researchers reporting a small-to-moderate treatment effect.
InSilicoTrials' platform will test patient-specific models that track dangerous immune and inflammatory responses in critically ill patients.
The Neuralink competitor has raised $430 million in total as it works to commercialise its wireless brain-computer interface (BCI) system.
Despite the incident occurring in June, the government wasn't notified until a few weeks ago, when an email was sent to a public mailbox.
The deal follows a $787-million financing for Earendil, backed by Sanofi and Pfizer.
Conference News
Distribution agreement with ContraCare GmbH to launch DERMALYTICA, which brings DermaSensor’s AI-powered skin cancer detection technology to physicians in GermanyMIAMI & NUREMBERG, Germany--(BUSINESS ...
September 28, 2026New global State of Type 2 Report uncovers three interconnected challenges in Type 2 diabetes care: health literacy, technology literacy and systemic access.1New partnership reinforc...
Potential workflow illustrates how patient workflow coordination in GE HealthCare's Intelligent Radiation Therapy ™ (iRT) software solution could connect to targeted charge review in S!GNALNewswise — ...
MILAN--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world’s smallest, durable automate...
New global State of Type 2 Report uncovers three interconnected challenges in Type 2 diabetes care: health literacy, technology literacy and systemic access.1New partnership reinforces Dexcom’s commit...
